A detailed history of Wintrust Investments LLC transactions in Amgen Inc stock. As of the latest transaction made, Wintrust Investments LLC holds 15,245 shares of AMGN stock, worth $4.91 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
15,245
Previous 15,340 0.62%
Holding current value
$4.91 Million
Previous $4.36 Million 9.22%
% of portfolio
0.43%
Previous 0.38%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $24,961 - $30,334
-95 Reduced 0.62%
15,245 $4.76 Million
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $80,392 - $97,043
299 Added 1.99%
15,340 $4.36 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $6.78 Million - $7.65 Million
-26,530 Reduced 63.82%
15,041 $4.33 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $297,145 - $368,914
1,359 Added 3.38%
41,571 $11.2 Million
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $2.64 Million - $3.12 Million
-12,311 Reduced 23.44%
40,212 $8.93 Million
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $103,411 - $126,041
458 Added 0.88%
52,523 $12.7 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $9.35 Million - $11.9 Million
40,821 Added 363.05%
52,065 $13.7 Million
Q3 2022

Nov 08, 2022

BUY
$224.46 - $253.15 $62,624 - $70,628
279 Added 2.54%
11,244 $2.53 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $124,814 - $138,896
541 Added 5.19%
10,965 $2.67 Million
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $28,724 - $31,776
-131 Reduced 1.24%
10,424 $2.52 Million
Q4 2021

Feb 04, 2022

BUY
$198.88 - $227.6 $169,048 - $193,460
850 Added 8.76%
10,555 $2.38 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $466,144 - $546,145
2,196 Added 29.24%
9,705 $2.06 Million
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $43,913 - $48,718
188 Added 2.57%
7,509 $1.83 Million
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $1.62 Million - $1.89 Million
7,321 New
7,321 $1.82 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $1.63 Million - $1.81 Million
-6,942 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$197.81 - $242.74 $46,485 - $57,043
235 Added 3.5%
6,942 $1.64 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $237,094 - $314,451
1,301 Added 24.07%
6,707 $1.36 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $48,248 - $62,016
255 Added 4.95%
5,406 $1.3 Million
Q3 2019

Nov 07, 2019

SELL
$174.11 - $208.62 $9,227 - $11,056
-53 Reduced 1.02%
5,151 $997,000
Q2 2019

Aug 05, 2019

SELL
$166.7 - $195.41 $160,365 - $187,984
-962 Reduced 15.6%
5,204 $0
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $491,242 - $553,738
-2,716 Reduced 30.58%
6,166 $1.17 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $1.15 Million - $1.34 Million
6,445 Added 264.46%
8,882 $1.83 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $19,084 - $21,515
-103 Reduced 4.06%
2,437 $505,000
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $38,025 - $42,710
229 Added 9.91%
2,540 $469,000
Q1 2018

May 03, 2018

SELL
$169.43 - $198.0 $51,337 - $59,994
-303 Reduced 11.59%
2,311 $394,000
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $51,818 - $57,897
307 Added 13.31%
2,614 $455,000
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $385,938 - $440,637
2,307
2,307 $430,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wintrust Investments LLC Portfolio

Follow Wintrust Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wintrust Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wintrust Investments LLC with notifications on news.